Toxicity of botulinum toxin type F (botF)
Montal M. Botulinum neurotoxin: a marvel of protein design. Annu Rev Biochem. 2010;79():591–617. doi: 10.1146/annurev.biochem.051908.125345. PMID: 20233039.; Rummel A, Häfner K, Mahrhold S, Darashchonak N, Holt M, Jahn R, Beermann S, Karnath T, Bigalke H, Binz T. Botulinum neurotoxins C, E and F bind gangliosides via a conserved binding site prior to stimulation-dependent uptake with botulinum neurotoxin F utilising the three isoforms of SV2 as second receptor. J Neurochem. 2009 Sep;110(6):1942–54. doi: 10.1111/j.1471-4159.2009.06298.x. PMID: 19650874.; Fu Z, Chen C, Barbieri JT, Kim JJ, Baldwin MR. Glycosylated SV2 and gangliosides as dual receptors for botulinum neurotoxin serotype F. Biochemistry. 2009 Jun 23;48(24):5631–41. PMID: 19476346; PMCID: PMC2709598.; Hatheway CL. Botulism: the present status of the disease. Curr Top Microbiol Immunol. 1995;195():55–75. doi: 10.1007/978-3-642-85173-5_3. PMID: 8542759.; Yamasaki S, Baumeister A, Binz T, Blasi J, Link E, Cornille F, Roques B, Fykse EM, Südhof TC, Jahn R. Cleavage of members of the synaptobrevin/VAMP family by types D and F botulinal neurotoxins and tetanus toxin. Journal of Biological Chemistry. 1994 Apr;269(17):12764–72. doi: 10.1016/s0021-9258(18)99941-2.